Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Campath-1H induction therapy and the
associated lymphocyte depletion will permit long-term, rejection free renal allograft
function in the absence of maintenance calcineurin inhibitor (CI) therapy.